What is your preferred sequence of chemotherapy regimens after patients with metastatic endometrial cancer develop resistance to carboplatin + paclitaxel?

Topics: Gynecologic Cancers • Medical Oncology

Answer from: Medical Oncologist at Academic Institution

This is a bit of an 'it depends' answer. If the patient has large volume disease or is highly symptomatic I will generally switch to liposomal doxorubicin. However, if the patient has more minimal disease, disease that is not imminently dangerous (nodal disease, pulmonary nodules) I will...

Comments

Medical Oncologist at Heartland Cancer Center
Do you consider ER receptor testing or tumor grade...

Medical Oncologist at University of Pittsburgh Magee Womens Hospital
Typically no -- Anecdotally (and in the literature...

Related Questions